Recombinant KRT20 抗体 (AA 196-323)
Our Local Distributor
北京 101111
Quick Overview for Recombinant KRT20 抗体 (AA 196-323) (ABIN7871715)
抗原
See all KRT20 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 196-323
-
原理
- Recombinant CK20 Antibody / Cytokeratin 20
-
纯化方法
- Protein A affinity chromatography
-
免疫原
- A recombinant human partial protein (amino acids 196-323) was used as the immunogen for this Cytokeratin 20 antibody.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal dilution of the recombinant CK20 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.2 mg/mL
-
缓冲液
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the recombinant CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- KRT20 (Keratin 20 (KRT20))
-
别名
- CK20
-
背景
- This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.
-
UniProt
- P35900
抗原
-